Menopause, Joint Pain and Frozen Shoulder

Menopause can contribute to joint pain and frozen shoulder because falling estrogen removes an anti-inflammatory signal from joint tissue. Frozen shoulder (adhesive capsulitis) is a painful stiffening of the shoulder capsule that affects up to 5% of the population, with most cases occurring in peri- and postmenopausal women. This page answers the questions women and clinicians ask most, and shows where measuring chronic inflammation with GlycanAge fits into the picture. For the wider context, see Menopause, HRT & Biological Age: The Definitive Guide to Tracking Hormonal Aging.

Can menopause cause joint pain?

Menopause can cause joint pain because estrogen helps regulate inflammation, and its decline removes that protection. Estrogen is an inflammatory regulator that plays a role in preventing arthralgia, the subjective experience of joint pain. More than 70% of women will experience musculoskeletal symptoms, and 25% will be disabled by them, through the transition from perimenopause to postmenopause. Pain increases across the menopausal transition and peaks in early postmenopause. If you are new to aching joints in your 40s or 50s, note when they began relative to changes in your cycle, sleep, and hot flashes, and bring that timeline to your clinician.

Can menopause cause frozen shoulder?

Menopause is associated with frozen shoulder, but a direct causal link is not yet proven. Frozen shoulder is most commonly experienced by women between 50 and 60, which coincides with the average age of menopause in the U.S., 52. Mechanistic studies suggest the onset of the condition is associated with hormonal involvement, specifically estrogen. Diabetes and hypothyroidism are also recognized risk factors, so a clinician will usually look at metabolic and thyroid health alongside hormones. Two trials are now testing HRT (hormone replacement therapy) in women with frozen shoulder, one at UCSF and one comparing physiotherapy outcomes with and without HRT.

Why does falling estrogen affect the shoulder and other joints?

Estrogen acts on joint tissue directly, so losing it changes how joints repair, lubricate, and signal pain. Estrogen receptors run through joint cells, and when estrogen binds them, they produce fewer of the cytokines (inflammatory chemical signals) that create swelling. Estrogen also nudges joint cells to build the collagen that keeps cartilage thick. When estrogen falls, swelling builds, cartilage disappears faster than the body rebuilds it, and pain registers more sharply. In frozen shoulder specifically, the hallmark is capsular inflammation and fibrosis, with progressive pain and loss of mobility.

What is the link between menopause, inflammaging, and joint pain?

Inflammaging is the slow accumulation of chronic, low-grade inflammation that drives biological aging, and menopause accelerates it. The term describes a hypothesis in which the immune system’s persistent, low-level inflammatory activity causes microscopic tissue damage and a self-reinforcing cycle of repair and further inflammation.

“The low-grade chronic inflammation which happens all around the body all the time is consuming a huge amount of energy, and at the same time it’s leaving these microscopic scars of damage. That damage gets repaired, but the repair itself promotes more inflammation — it’s actually a vicious circle which leads to aging.”

— Prof. Gordan Lauc, Professor of Biochemistry and Molecular Biology, University of Zagreb, and Co-Founder & Chief Scientific Officer, GlycanAge

The mechanism sits in glycans, complex sugars attached to IgG (Immunoglobulin G) antibodies that act as switches for immune inflammation. As estrogen declines in perimenopause, these glycans shift from an anti-inflammatory to a pro-inflammatory profile, which is linked to joint pain, cardiovascular risk, and accelerated biological aging.

Is my joint pain menopause, overtraining, or something else?

Joint and muscle pain has many causes, so menopause is one possibility to rule in or out with your clinician, not a conclusion to reach alone. Musculoskeletal pain can stem from aging, physical strain, injuries, and autoimmune diseases.

“What is really important is looking at their symptoms, but the symptoms really vary. Some women just might get some muscle or joint pains; they might get headaches or worsening migraines; they might get low mood, feeling irritable, feeling more forgetful.”

— Dr. Louise Newson, GP and Menopause Specialist, Founder of Newson Health Menopause & Wellbeing Center and the Balance App

One woman in our podcast archive described heavy resistance training followed by severe muscle fatigue and pain. She tried osteopathy and chiropractic adjustments without relief, and later recognized the pattern as a possible sign of active perimenopause. If pain tracks with your cycle, sleep disruption, or hot flashes rather than with a specific injury or training load, raise menopause explicitly.

Can a hormone blood test confirm a menopause link?

A single hormone blood test often cannot, because perimenopausal hormone levels swing unpredictably. Dr. Louise Newson explains that estrogen levels are haphazard in perimenopause, so a FSH (follicle stimulating hormone) test can appear normal or even suppressed in that snapshot. Standard tools are not built to capture a moving target. A GlycanAge test measures something different: the IgG glycan profile that reflects ongoing chronic inflammation rather than a momentary hormone level. It is not a diagnostic tool and cannot confirm menopause. It gives you and your clinician a stable inflammatory baseline to read alongside symptoms and history.

Does HRT help with joint pain and frozen shoulder?

HRT can ease joint pain for some women, but it is not an established treatment for joint pain alone. Mass General Brigham notes that several studies suggest modest improvement in joint pain, though menopausal hormone therapy is not recommended solely for joint pain without vasomotor symptoms. For frozen shoulder, evidence is early: in one analysis, 3.95% of women who received HRT were diagnosed with frozen shoulder versus 7.65% of those who did not, a difference that was not statistically significant.

Decisions about HRT belong with your clinician, who weighs your personal and family history.

How can I tell whether HRT or lifestyle changes are lowering my inflammation?

You can tell by tracking an inflammation biomarker that responds to intervention and stays stable when nothing changes. Pain scores and symptom diaries are useful but subjective. Biological age testing with GlycanAge responds faster to intervention than other aging clocks: meaningful improvements can appear within 3 to 4 months of a pharmaceutical or HRT intervention, or 6 to 12 months of a lifestyle change. Epigenetic clocks, by contrast, can vary by up to 10 years on repeat measurement, while GlycanAge repeat measurements vary by approximately 1 year. Take a baseline before starting HRT, an anti-inflammatory nutrition plan, or a strength and mobility program. Retest at 3 to 4 months if you started HRT, or 6 to 12 months if you changed diet, training, or sleep habits, and book your 1:1 Result Interpretation Call to translate the change into next steps. Across repeat testers, the average biological age reduction is 6 years, and 96% report being extremely satisfied with their interpretation call.

What else supports joints during menopause?

Strength training, low-impact movement, sleep, and diet all support joint health during menopause, and each can be tracked. Poor sleep, muscle loss, weight gain, and inactivity can all make joint pain worse. Strength training, low-impact exercise, and an anti-inflammatory diet can help support joint health. The woman in our podcast archive who felt inflamed after hard training shifted toward yoga, Pilates, stretching, and gentle movement. For frozen shoulder that does not respond to physiotherapy, the traditional stepwise approach runs from anti-inflammatory drugs and steroid injections through physical therapy to surgery, which is a decision for an orthopedic specialist.

If joint pain or a stiff shoulder has arrived alongside other menopausal changes, measure the inflammation behind it rather than guessing. Order a GlycanAge test kit to take your baseline, then retest after 3 to 4 months of HRT, or 6 to 12 months of lifestyle changes, to see whether your biology is moving. Clinicians can see how to build GlycanAge into menopause care on the Healthcare Providers page.

External sources

• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT07278323, Hormone Replacement Therapy as an Adjunct Treatment for Adhesive Capsulitis of the Shoulder (Frozen Shoulder) in Peri- and Postmenopausal Women; [cited 2026 Oct 19]. Available from: https://clinicaltrials.gov/study/NCT07278323

• Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024;27(5):466-72. Available from: https://doi.org/10.1080/13697137.2024.2380363

• Tamai K, Akutsu M, Yano Y. Primary frozen shoulder: brief review of pathology and imaging abnormalities. J Orthop Sci. 2014;19(1):1-5. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3929028/

• Office on Women’s Health [Internet]. Washington (DC): U.S. Department of Health and Human Services. Menopause basics; [cited 2026 Oct 19]. Available from: https://www.womenshealth.gov/menopause/menopause-basics

• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT07736027, Effect of Hormone Replacement Therapy on Physiotherapy Outcomes in Postmenopausal Women With Frozen Shoulder; [cited 2026 Oct 19]. Available from: https://clinicaltrials.gov/study/NCT07736027

• Mass General Brigham [Internet]. Somerville (MA). Menopause and joint pain; [cited 2026 Oct 19]. Available from: https://www.massgeneralbrigham.org/en/health-wellness/menopause-and-joint-pain

• Rapčan B, Song M, Frkatović-Hodžić A, Pribić T, Vuk J, Beletić A, et al. Glycan clock of ageing—analytical precision and time-dependent inter- and intra-individual variability. Geroscience. 2024;46(6):5781-96. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11494675/